AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE II

CAS: 58943-39-8 ENZYME

Aminoglycoside 3'-phosphotransferase II is an enzyme used as a food additive in certain genetically engineered crops to confer resistance against aminoglycoside antibiotics through phosphorylation.

What It Is

Aminoglycoside 3'-phosphotransferase II is a bacterial enzyme identified by CAS number 58943-39-8 and belongs to the class of phosphotransferases that catalyze the transfer of a phosphate group to aminoglycoside antibiotics such as kanamycin and neomycin. It is also referred to as APH(3')II or NPTII and is commonly encoded by the kanr gene originally isolated from bacterial transposon Tn5. In the context of food use, this enzyme appears in genetically modified plants as part of the selection marker system that permits plant cells carrying desired genetic traits to survive antibiotic selection during development. This enzyme alters the chemical structure of certain aminoglycosides, reducing their antibiotic activity by adding a phosphate group. It is a protein composed of a sequence of amino acids that fold to form the catalytic site necessary for this transferase activity. Its presence in food products is tied to the selection process for genetically engineered traits rather than a direct nutritional or processing function. Despite its bacterial origin and biochemical activity, regulatory agencies permit its use under specific conditions governed by food additive regulations, ensuring that the enzyme's presence in the final food does not exceed levels reasonably required for its intended technological function. Its definition as a food additive is technical and tied to its role in development of genetically modified crops.

How It Is Made

Aminoglycoside 3'-phosphotransferase II is produced through recombinant DNA technology where the gene encoding this enzyme (typically from the bacterium Escherichia coli) is inserted into a host organism or plant genome to express the enzyme. In the laboratory or biotechnology setting, standard molecular biology techniques are used to clone and express this gene under controlled promoters so that the enzyme is synthesized in the host cells. The manufacturing process starts with identifying and isolating the DNA sequence that encodes the enzyme, often from a bacterial transposon such as Tn5. This DNA sequence is then inserted into a plasmid or other genetic vector that can be transferred into plant cells or another host. During plant transformation, cells that incorporate the kanr gene along with an introduced trait of interest are selected by growing them in the presence of specific aminoglycoside antibiotics. Those cells expressing sufficient levels of the phosphotransferase enzyme survive due to their ability to phosphorylate and thereby inactivate the antibiotic. After successful selection and regeneration of plants, the enzyme may be present in trace amounts corresponding to the genetic modification. This process does not describe the isolation of the purified enzyme for use as an independent food additive in ingredient form, but rather its role within the genetically engineered plant tissues. Regulatory contexts ensure that the use and residual amounts of the enzyme align with approved guidelines.

Why It Is Used In Food

This enzyme is used in the development of genetically modified crops where it functions as a selectable marker during genetic engineering. Because plants expressing this enzyme can inactivate specific antibiotics, developers use aminoglycoside antibiotics in tissue culture to identify cells that have successfully integrated a gene of interest. Only those cells expressing the resistance marker survive, facilitating the efficient selection of transformed cells. The enzyme itself is not added for sensory, nutritional, or processing reasons; its purpose is technological and tied to the early stages of crop development. Regulatory frameworks permit its presence in food derived from such crops under strict conditions where the levels present do not exceed what is necessary for selection and where safety assessments support its consumption. The use of this enzyme supports genetically modified traits such as herbicide tolerance or improved agronomic characteristics by enabling scientists to isolate and propagate successful modifications.

Adi Example Calculation

An illustrative explanation of acceptable daily intake (ADI) normally involves comparing potential daily exposure to a threshold deemed safe by regulatory authorities. In the case of conventional food additives, an ADI might be expressed in milligrams per kilogram of body weight per day. This illustrative example highlights how such calculations work conceptually rather than applying to this specific enzyme, which does not have an established numeric ADI. Imagine a hypothetical additive with an ADI of 1 mg per kilogram body weight per day established by a regulator. For a person weighing 70 kilograms, the total allowable daily intake would be 70 mg of that additive. This calculation simply multiplies the ADI by body weight. However, aminoglycoside 3'-phosphotransferase II is not assigned a numeric ADI because its presence in food is incidental at trace levels tied to genetic engineering and not as a direct functional additive in food processing. For amino acid–based proteins like this enzyme, typical dietary exposure is orders of magnitude lower than thresholds of toxicological concern, and digestion breaks the protein down similarly to other dietary proteins. This example serves only to illustrate how ADI values are applied in contexts where numeric values are established, which is not the case for aminoglycoside 3'-phosphotransferase II.

Safety And Health Research

Safety assessments of aminoglycoside 3'-phosphotransferase II focus on its origin, molecular structure, and potential to provoke unintended biological effects in humans. Because this enzyme originates from bacteria and is used as a selectable marker in genetically engineered crops, food safety authorities review data on its digestibility, potential allergenicity, and overall exposure levels in food products. Proteins that are readily digested and lack structural similarity to known allergens or toxins are generally considered low risk. There is no direct clinical evidence indicating adverse health outcomes from consumption of this enzyme at trace levels in food. Instead, safety evaluations typically consider whether residual levels present in food are negligible and unlikely to elicit biological activity in the human digestive tract. Regulatory bodies examine the genetic construct, expression levels in edible plant tissues, and biochemical properties of the protein to ensure its safety. Because enzymes are proteins, they are expected to break down into amino acids during digestion like other dietary proteins, minimizing concern for systemic effects. Scientific literature on this specific enzyme emphasizes its catalytic role in antibiotic inactivation in bacterial systems rather than effects on human health from dietary exposure. As with many proteins derived from genetically modified organisms, the primary safety question involves allergenicity, and no evidence suggests that aminoglycoside 3'-phosphotransferase II is a known allergen. The regulatory framework incorporates evaluation of such data as part of comprehensive safety reviews of genetically modified crops that contain this selectable marker.

Regulatory Status Worldwide

In the United States, aminoglycoside 3'-phosphotransferase II is recognized in Title 21 of the Code of Federal Regulations at section 173.170 as a secondary direct food additive permitted in food for human consumption under prescribed conditions. This regulation allows the enzyme to be used in the development of genetically modified cotton, oilseed rape, and tomatoes, provided that the level of the additive does not exceed the amount reasonably required for selection of plant cells carrying the kanr gene along with the genetic material of interest. The regulatory citation for this allowance is 21 CFR 173.170. There is no evidence that this enzyme has an established food additive number (INS or E-number) in the European Union, nor is there indication of a specific acceptable daily intake (ADI) determined by international bodies such as JECFA. Evaluations by food safety authorities focus on the safety of the genetically modified organism as a whole rather than assigning a standalone ADI to this enzyme itself. In jurisdictions where genetically modified organisms undergo premarket safety assessment, regulators review molecular characterization, potential allergenicity, and toxicological data relevant to the engineered trait and any associated selectable markers. Regulatory approaches to such enzymes vary globally, with some regions requiring case-by-case assessment of genetically modified crops and their components before approval for cultivation or food use. The enzyme's regulatory status is therefore context-dependent and tied to broader policies governing food biotechnology and genetically modified organisms.

Taste And Functional Properties

Aminoglycoside 3'-phosphotransferase II is an enzyme and, like most proteins, does not contribute to the taste, aroma, or texture of food in any appreciable way. Enzymes generally lack perceptible taste and are present in extremely low concentrations in food products derived from genetically engineered plants. Consequently, this additive does not meaningfully influence sensory characteristics such as sweetness, bitterness, or mouthfeel. From a functional standpoint within biological systems, the enzyme catalyzes a biochemical reaction involving transfer of a phosphate group from ATP to a target molecule. This catalytic activity is specific to aminoglycoside antibiotics and is not relevant to typical food chemistry processes such as fermentation, browning, or flavor development. The enzyme is biologically active in the context of selectable marker systems during crop development but is functionally inert with respect to digestibility or nutrient metabolism at trace levels found in food. Proteins can be sensitive to heat and pH changes, and this enzyme is likely denatured during cooking or processing. Denaturation typically abolishes enzymatic activity without producing harmful compounds, rendering the protein inactive. As an ingredient present due only to genetic engineering selection, it does not impart functional effects on food properties encountered by consumers.

Acceptable Daily Intake Explained

The concept of an acceptable daily intake (ADI) relates to the amount of a substance that can be consumed daily over a lifetime without appreciable health risk. For conventional food additives with direct additive use, regulatory agencies often establish an ADI based on toxicological studies and safety factors. However, aminoglycoside 3'-phosphotransferase II is not assigned a specific ADI in major regulatory databases because it is associated with genetically modified crops as a selectable marker rather than used directly as a conventional additive. In practice, exposure to this enzyme from food products is expected to be extremely low and most likely negligible after typical food processing, which can denature proteins. Because it is a protein, it is digested like other dietary proteins into constituent amino acids in the gastrointestinal tract. Safety assessments instead focus on ensuring that the presence of the enzyme does not introduce allergenic or toxic responses at trace levels in food. When regulatory authorities evaluate genetically engineered crops containing this enzyme, they consider the potential exposure in the context of overall dietary intake, protein digestibility, and lack of known harmful effects. Therefore, explicit numeric ADI values may not be determined for this enzyme itself, and discussions about intake emphasize regulatory review and the expectation that residual amounts, if any, are minimal.

Comparison With Similar Additives

Aminoglycoside 3'-phosphotransferase II differs from conventional food additives such as amylases, lipases, and cellulases, which are enzymes added directly to food products to catalyze processing functions like starch breakdown or fat modification. Those processing enzymes have direct technological roles in food manufacturing and defined use levels, whereas aminoglycoside 3'-phosphotransferase II is present due to genetic engineering selection. In contrast to flavor enhancers (e.g., glutamates) or preservatives (e.g., sorbates), this enzyme does not impact sensory qualities, shelf life, or microbial stability of food. Its role in biotechnology parallels other selectable marker enzymes such as hygromycin phosphotransferase, which provides resistance to the antibiotic hygromycin during plant transformation. Both serve as tools in genetic engineering rather than additives chosen for food formulation. Comparing to enzymes like lactase used to reduce lactose in dairy products, aminoglycoside 3'-phosphotransferase II does not interact functionally with common food constituents in the consumer setting. Instead, its relevance is limited to the development stage of certain genetically modified crops. Consequently, its regulatory evaluation and applications are distinct from typical enzymes and other food additives that have established functions and use levels in food production.

Common Food Applications Narrative

Aminoglycoside 3'-phosphotransferase II appears indirectly in food through its association with certain genetically modified crops. These crops include varieties of cotton, oilseed rape (canola), and tomatoes that have been engineered for specific traits such as improved agronomic performance or stress tolerance. During the development of these plants, the enzyme functions as a biological marker that allows researchers to identify and propagate cells that have successfully incorporated the desired genetic modification. The presence of this enzyme in the final food products derived from such crops is not for taste, nutrition, or processing benefits, but rather a consequence of the underlying genetic engineering process. When the genetically modified plants are cultivated, harvested, and processed into food or food ingredients, trace amounts of this enzyme may remain. Consumers encounter these foods in forms such as seed oil from canola, processed tomato products, and cottonseed-derived components, although typical food processing steps may denature the protein. Food safety authorities assess such uses to ensure that the enzyme's presence does not pose a risk to consumers and that its levels remain within the parameters established by regulations. As a result, its inclusion in the food supply is tightly controlled and monitored through regulatory frameworks that govern genetically modified organisms and the additives associated with their development.

Safety & Regulations

FDA

  • Notes: Approved for use under conditions in 21 CFR 173.170 allowing enzyme in development of genetically modified crops.
  • Regulation: 21 CFR 173.170

EFSA

  • Notes: No specific EFSA additive number or ADI publicly available.

JECFA

  • Notes: JECFA assessment not explicitly available for this enzyme.

Sources

Comments

No comments yet. Be the first to share!